Figure 1From: Adjuvant zoledronic acid therapy for patients with early stage breast cancer: an updated systematic review and meta-analysis Forest plots from a meta-analysis of overall survival (A), disease-free survival (B), bone metastasis-free survival (C), distant metastasis-free survival (D), and fracture-free rate (E) for the adjuvant use of zoledronic acid compared to the control arm. Back to article page